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     The usual assessment instruments for the diagnosis of 
dementia are often difficult to use when evaluating the 
disorder among individuals with mental retardation.  This 
study investigates whether a modified method based on 
Visser et al. (1997) can identify a dementing process.  
Ninety individuals diagnosed with severe and profound 
mental retardation were studied.  One half of the 
participants were diagnosed with Down’s syndrome.  The 
participants were equally assigned to one of three groups 
based on perceived risk for dementia.  A differential 
prevalence design was used.  Both cross sectional and 
longitudinal analyses were utilized in this study.  Results 
indicate that the Visser et al. (1997) method is effective 
in identifying dementia.  Differences between syndrome and 
risk of dementia groups will be discussed. 
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Introduction 
A significant growth in the elderly population with 
mental retardation (MR) has been noted in recent years (Deb 
& Janicki, 1995; Janicki, 1994; World Health Organization, 
2000).  With this increase, there is a greater proportion 
of older persons who develop age related changes affecting 
their cognitive, physical, emotional and adaptive 
functioning (Cherry, Matson & Paclawsky, 1997; Kapell et 
al., 1998).  These physical differences include failing 
senses, lessened attentiveness, declining agility, 
difficulties with mobility, reduced resistance to disease, 
difficulty in recovering from illness and injury, decreased 
stamina, depression and anxiety (Anderson, 1993; Evenhuis 
et al., 2001; Moss et al., 1993; Williams, 1995).  
Increases in the prevalence of age associated psychiatric 
diseases such as Alzheimer’s disease and other dementias 
have also been noted.  Researchers have shown that 
individuals with mental retardation, particularly those 
diagnosed with Down’s syndrome, are at an even greater risk 
for dementia than the general population (Burns, 1992; 
Zigman, Silverman & Wisniewski, 1996).   
Several types of dementia have been identified (i.e., 
Alzheimer’s disease, vascular dementia, frontal lobe 
dementia, subcortical dementia and dementia due to HIV or 
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other general medical conditions).  Some forms of the 
disorder are reversible (i.e., dementia caused by 
hypothyroidism, drug induced dementia)(Coffey & Cummings, 
1994), therefore careful assessment is important to 
distinguish irreversible dementia from reversible dementia 
or dementia due to a treatable condition (Kaplan, Sadock, & 
Grebb, 1994).  Best practices for the assessment of 
dementia among individuals in the general population using 
clinical interview, physical exams, and neurological 
testing are clearly established and have been conducted for 
many years (Coffey & Cummings, 1994).  However, the 
standard of care in diagnosis of dementia among individuals 
with mental retardation is less clear.  The diagnosis of 
dementia in persons with developmental disabilities, 
especially in the early stages, is made difficult by the 
lack of reliable and standardized criteria and diagnostic 
procedures and the trouble of detecting declines against 
the already impaired background of developmental disability 
(Aylward, Burt, & Thorpe, 1997).  Thus far, the DSM-IV 
(APA, 1994) does not provide any information regarding how 
to diagnose aging individuals with dementia and mental 
retardation.  Perhaps this state of affairs can be 
attributed to standard methods of dementia assessment 
(i.e., cognitive evaluations, mental status examinations, 
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and neuropsychological tests) that appear to be 
inappropriate to diagnose persons who have presented with 
cognitive delays since childhood (Haveman, Maaskant & von 
Schrojenstein, 1994).  Therefore, researchers have begun to 
address the issue of diagnosing dementia in individuals 
with developmental delays.   
Aging in the Developmentally Disabled 
The number of individuals that comprise the “elderly 
population” is rapidly on the rise (Janicki, Dalton, 
Henderson & Davidson, 1999). According to the 2000 US 
Census, there are approximately 35 million people age 65 
years or older.  This dramatic increase in life expectancy 
can be attributed to advances in medicine, public health, 
science, education and technology (World Health 
Organization, 2000).  
Additionally, owing to more readily available 
supportive services to individuals with mental retardation 
(MR), a much greater proportion of persons with 
developmental disabilities are reaching old age (Bittles et 
al., 2002; Das & Mishra, 1995).  For instance, persons with 
Down’s syndrome had a life expectancy of less than 10 years 
in 1929, but with advances in cardiac care and surgical 
procedures as well as the availability of general community 
health care systems, the life expectancies of these 
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individuals have significantly increased (Zigman, Schupf, 
Haverman & Silverman, 1995).  Over 40% of live-born Down’s 
infants now survive 60 years (Holland, 1999; Yang, 
Rasmussen & Friedman, 2002).  The life expectancies of non-
Down’s syndrome persons with MR have dramatically changed 
too.  The average age of death for persons with 
intellectual disabilities in 1931 was 22 years.  This age 
had increased to 59 years by 1976 and to 66.1 years by 1993 
(Janicki et al., 1999).  Researchers estimate that, 
worldwide, there are as many as 60 million persons who 
currently have some level of developmentally related 
cognitive impairment (World Health Organization, 2000) and 
there are between 200,000 and 500,000 older adults with MR 
in the United States (Janicki & Dalton, 2000).  This older 
age group will likely double by the year 2025 
(Rehabilitation Research and Training Center, 1995).  In 
fact, some researchers believe that this “old age” MR 
population could reach anywhere between 700,000 to 
4,000,000 in the next 20 to 30 years (Silverman et al, 
1998).  As these survival rates are gradually approaching 
that of the general population, researchers have begun to 
focus on age-related health conditions (e.g., physical and 




 Researchers have found that the combination of mental 
retardation and aging may create additional difficulties 
for an individual (LeBlanc & Matson, 1997). Campbell and 
Herge (2000) advocate that individuals with MR often 
experience a need for additional support due to 
physiological and psychological changes associated with 
aging.  Common age related physical changes that are 
experienced by both the general and developmentally 
disabled populations include hearing and visual impairment, 
decreased muscle mass and flexibility, and increased 
incidence of arthritis, hypertension, heart disease, 
diabetes, and osteoporosis (Anderson, 1993; Evenhuis et 
al., 2001; Janicki & Dalton, 1998; Moss et al., 1993).  
Although these conditions are common to both the 
developmentally disabled and the general populations, 
individuals with mental retardation have a higher incidence 
of death, disease, and disability.   For instance, persons 
with mental retardation have been identified as a 
“population at risk” because of their poor nutrition 
decisions and sedentary lifestyle (Petitti & Campbell, 
1991).  Although researchers have found that a third of all 
Americans are overweight, obesity among individuals with 
mental retardation (particularly females) is even higher 
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(US Department of Health and Human Services, 2002).  In 
fact, close to half of all people with developmental delays 
are overweight (Special Olympic Report, 2001).  The 
prevalence of obesity increases among individuals with 
Down’s syndrome.  Prasher and Chung (1996) found that 52% 
of their participants who were diagnosed with Down’s 
syndrome were clinically obese.  Braunschweig and 
colleagues (2004) reported that 89% of Down’s syndrome 
participants in their study on nutrition were overweight or 
obese.  The high levels of excess fat found in people with 
developmental disabilities expose them to a higher risk for 
many different types of disease associated with obesity.  
Researchers have also noted that individuals with mental 
retardation are at risk for various diseases (e.g., 
vascular disease, diabetes, hypertensive encephalopathy, 
etc.) that result from physical inactivity (Rimmer, 1994).   
Researchers have noted that some underlying 
characteristics and commonalities typical to individuals 
with mental retardation may also have adverse effects on 
their health.  For example, individuals with cognitive 
disabilities may have difficulty accessing emergency health 
services (Spreat & Conroy, 2001).  Persons with 
communication deficits are likely to have difficulty 
communicating with health care providers (Moss, 1995).  
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Also, researchers have found that people with mental 
retardation are more likely to be prescribed medication 
than individuals in the general population (Kumar & 
Brecher, 1999; Young & Hawkins, 2002).  If these 
individuals, rather than their caretakers, are responsible 
for following their medication regime, rates of medication 
non-compliance due to forgetfulness increases drastically 
(Torr & Chiu, 2002).  Also, people with a long life history 
of taking certain medications (e.g., anticonvulsants, 
neuroleptics) are at a higher risk of developing secondary 
conditions (e.g., osteoporosis, tardive dyskinesia) 
(Zubenko & Sunderland, 2000).  Finally, several 
disabilities have been found to be associated with their 
primary diagnosis and syndromes (e.g., Down’s syndrome is 
associated with a high incidence of thyroid disorder, 
cardiac myopathy, and senile dementia of the Alzheimer’s 
type).    
Psychological Changes 
Similarly to physical health, there are also 
psychological issues related to aging.  Historically, many 
professionals believed that persons with mental retardation 
were incapable of developing emotional problems because of 
their lack of “proper ego strength” (Reiss, Levitan, & 
Szyszko, 1982).  Practitioners assumed that odd or strange 
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behaviors in persons with developmental disabilities were 
simply due to the individual’s cognitive limitations.  The 
term “diagnostic overshadowing” was coined in 1982 because 
mental retardation was said to “overshadow” the symptoms of 
psychological disturbance (Reiss, 1994; Reiss, Levitan, & 
Szyszko, 1982).   
Experts in the field have made great strides in the 
past two decades in identifying and diagnosing mental 
illness in persons with mental retardation.  As a result, 
it has been well documented that individuals with 
developmental delays are susceptible to the full range of 
emotional and personality disorders (Davidson et al., 1994; 
Matson & Barrett, 1993; Reiss, 1994). Additionally, the 
data gathered suggests that the prevalence of these 
disorders in the mentally retarded population is higher 
than that of the general population (Dudley, Ahlgrim-Delzel 
& Calhoun, 1999; Matson & Sevin, 1994; Moss et al., 1997; 
Rojahn & Tasse, 1996).  Prevalence rates of psychopathology 
ranging from 10 to 60% percent have been reported 
(Borthwick-Duffy, 1994; Davidson et al., 1994; Jacobson, 
1999; Matson & Barrett, 1994).  Despite the awareness of 
high rates of co-morbid psychiatric conditions among 
individuals with MR, researchers continue to show that 
behavioral and emotional difficulties are less likely to be 
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accurately acknowledged compared to disorders of persons of 
average intelligence (Jopp & Keys, 2001).  White et al. 
(1995) estimated that people with MR could expect a 19 
percent drop in diagnostic accuracy and mental health 
treatment recommendations in contrast to persons with 
comparable symptoms who do not have other disabilities. 
Although attempts to accurately diagnose individuals 
with developmental disabilities and co-morbid psychiatric 
problems continue to be substandard, researchers have 
demonstrated that the rate of psychopathology among persons 
with MR remains stable throughout their life span.  Cherry, 
Matson, and Packlawskyj (1997) investigated the prevalence 
of psychopathology in individuals with severe and profound 
mental retardation and found that the frequency of 
disorders was comparable for younger and older adults but 
older adults showed longer duration and/or greater severity 
ratings than did younger adults. The mental health problems 
prevalent in older individuals with mental retardation are 
consistent with those commonly found among aging persons of 
normal intelligence (i.e., anxiety, phobias, and 
depression) (Harper & Wadsworth, 1990; McNellis, 1997; 
Rojahn, Warren, & Ohringer, 1994).  Researchers have 
hypothesized that these psychiatric conditions can result 
from physiological changes, medical conditions, long term 
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pharmaceutical use, or changes in living situation or 
lifestyle (Moss et al., 1997).  In addition to high rates 
of mood, anxiety, and adjustment disorders, researchers 
have noted an increase in the prevalence of age-associated  
psychiatric disorders among persons with mental 
retardation.  One such condition is dementia associated 
with old age.   
Dementia 
Dementia is a syndrome where progressive deterioration 
in cognitive abilities is sufficiently severe to interfere 
with the individual’s usual social or occupational 
functioning or their level of personal adjustment (APA, 
1994).  This condition is neurologically based and requires 
the presence of memory problems plus one of the following: 
aphasia (difficulty in expressing thoughts as spoken 
words), apraxia (difficulty in carrying out simple, 
directed acts), agnosia (difficulty in interpreting 
familiar faces or other well-known objects), and 
disturbances in executive functioning (the ability to plan 
and organize).  Eventually, this problem has dramatic 
effects on how well a person is able to care for 
him/herself.  An estimated 5-15% of people 65 years of age 
and older are affected by a dementing disorder (Kaplan, 
Sadock, & Grebb, 1991; Riley, 1999).  Researchers have 
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found that several risk factors are associated with 
dementia.  These variables include a family history of 
dementia, low educational level, previous head trauma, 
cardiovascular disease, stroke, diabetes, apolipoprotein E-
4 allele and previous major depressive episode (Ravaglia, 
2002; Sliwinski, Buschke, Stewert, & Masur, 1997). 
Most adults with mental retardation are at the same 
risk for dementia as are older adults in the general 
population (McNellis, 1997; Zigman et al., 2004). Thus far, 
the only particular risk factor uniquely identified among 
people with mental retardation is Down’s syndrome (Dalton & 
Janicki, 1999).  Researchers have found that people with 
Down’s syndrome have significantly higher rates of dementia 
of the Alzheimer’s type (Holland, Hon, Hubert & Stevens, 
2000; Zigman, Silverman & Wisniewski, 1996) and prevalence 
increases in an exponential fashion past age 50.  
Approximately 25% of adults with Down’s syndrome age 40 to 
49 years, approximately 55% of those age 50 to 59 and about 
75% of adults age 60 years and older show the behavioral 
symptoms of dementia (Zigman, Schupf & Haveman, 1997).   
Although not every aging individual with Down’s 
syndrome goes on to show clinical manifestations of 
dementia (Devenney, Silverman, Hill, Jenkins, Sersen, & 
Wisniewski, 1996), upon autopsy, virtually all adults with 
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Down’s syndrome over the age of 40 show some evidence of 
the neuropathology associated with Alzheimer’s disease 
(Mann, 1993).  For instance, these individuals demonstrate 
deposition of beta-amyloid in diffuse and neuritic plaques 
and intracellular neurofibrillary tangles (Royston et al., 
1999).  This phenomenon appears to be due to the 
triplication of the genes for beta-amyloid precursor 
protein (B-APP), located on the proximal part of the long 
arm of chromosome 21 (Rumble et al., 1989; Schupf, 2002).  
Thus far, it is not clear what effect, if any, possible 
risk factors as seen in the general population have on 
people with Down’s syndrome (Zigman, Schupf & Haveman, 
1997).   
Although Alzheimer’s disease is the most common and 
most researched form of dementia, dementing disorders are a 
heterogeneous group of conditions.  Their etiology, 
neurological substrate, disease course, and treatment can 
vary greatly (Coffey & Cummings, 1994).  Twelve categories 
of dementia are outlined in DSM-IV.  They are Dementia of 
the Alzheimer’s type, Vascular Dementia, Dementia due to 
HIV Disease, Dementia due to Head Trauma, Dementia due to 
Parkinson’s Disease, Dementia due to Huntington’s Disease, 
Dementia due to Pick’s Disease, Dementia due to 
Creuitzfeldt-Jakob Disease, Substance Induced Persisting 
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Dementia, Dementia due to Multiple Etiologies, and Dementia 
due to Other Medical Condition (APA, 1994). Several types 
of dementia will be discussed next. 
Alzheimer’s Disease   
Alzheimer’s disease is the most common form of 
dementia – an illness associated with old age that impairs 
intellectual functions (e.g., memory, orientation, 
concentration, language, perception, executive 
functioning)(Schofield & Mayeux, 1998).  This disorder is a 
slow and progressive, degenerative disorder of the brain 
that eventually results in diminished brain function and 
death.  According to prevalence data, approximately 100,000 
victims die and 360,000 new cases are diagnosed each year 
(Small et al., 1997).  Researchers estimate that by 2050, 
14 million Americans will have this disease (Cummings & 
Cole, 2002).  As mentioned, Alzheimer’s disease is an age-
associated disorder but it is not a part of normal aging.  
The disease usually begins later in life (late onset – 
after age 60); however, it may affect persons as young as 
30 years of age (early onset).  Early onset AD results in 
about 5-10% of all cases (Cummings & Cole, 2002) and 
typically has a much faster course and progression of 
deterioration.    
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In the early stages of AD, the symptoms may be subtle.  
New or recent memory is typically impaired first, and the 
individual may find it hard to learn and retain new 
information. Eventually, older or distant memory also is 
lost. Next, other symptoms may appear, including aphasia, 
apraxia, agnosia, and disturbances in executive functioning 
(Grabowski & Damasio, 1997).  In practical terms, 
individuals with early AD commonly misplace things, 
frequently repeat statements, have trouble finding names 
for familiar objects, get lost on familiar routes, and lose 
interest in things they previously enjoyed.  However, 
despite all of these intellectual problems, Lowenstein 
(1990) found that many people with early Alzheimer's 
disease continue to be able to eat, bathe, dress and groom 
themselves as usual without assistance.  
Unfortunately, psychiatric symptoms (personality 
changes, irritability, anxiety, and depression) also may 
occur, and these may cause serious problems in 
relationships with family and friends (Balestreri, 
Grossberg, & Grossberg, 2000; Hargrave, Stoeklin, Haan, & 
Reed, 2000).  Personality changes have not been well 
specified and thus, have often gone unrecognized.  However, 
in recent years, it has become more widely known that some 
dementias can cause changes to an individual’s core 
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personality and social-affective functioning.  Researchers 
have demonstrated that personality change is a significant 
predictor of dementia, independent of cognition and 
functional status.  Smith-Gamble et al. (2002) assessed the 
predictive value of caregiver reports of changes in 
personality on incident dementia and Alzheimer’s disease.  
Subjects with changes in personality had approximately 
twice the odds of having dementia as subjects with no 
change in personality. 
As Alzheimer's disease progresses to its middle and 
late stages, there may be delusions (irrational beliefs, 
especially about being persecuted or having one's 
belongings stolen) and hallucinations (false sensations — 
seeing, hearing, smelling, tasting or being touched by 
something that isn't really there). The patient also may 
become aggressive or may begin to wander away from home if 
left alone (Riley, 1999). In the final stages of AD, a 
person can no longer function without assistance. Most 
people in this stage no longer understand language, they no 
longer recognize family members, and they can no longer 
perform basic activities of daily living such as eating, 
dressing, and bathing (Ballard et al., 2001).  
The rate that AD advances is different for each 
person.  If AD develops rapidly, it is likely to continue 
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to progress rapidly.  If the disease has been slow to 
progress, it will likely continue on a slow course.  The 
duration of the illness may often vary from 3 to 20 years.  
The assessment of dementia will soon be discussed but it is 
important to note that the diagnosis of Alzheimer’s is 
always a diagnosis of exclusion.  It is made based on 
characteristic symptoms and by excluding the other causes 
of dementia.  The diagnosis of Alzheimer’s disease can only 
be confirmed by microscopic examination of a sample of 
brain tissue after death (Rogan & Lippa, 2002). 
Vascular Dementia   
Vascular dementia (VD) is the second most common cause 
of dementia, accounting for approximately 20% of all cases 
alone and up to another 20% of cases in combination with 
Alzheimer’s disease (Pantoni & Inzitari, 2002).  VD is not 
a single disease but a group of syndromes associated with 
problems in circulation of blood to the brain (cerebra-
vascular disease).  Some subtypes of VD include: (1) multi-
infarct dementia, (2) VD due to strategic single infarct, 
(3) VD due to lacunar lesions, (4) VD due to hemorrhagic 
lesions, and (5) Binswanger disease.   
VD is characterized by uneven impairment in cognitive 
functioning and “patchy” performance on neuropsychological 
measures (Jefferson et al., 2002). For instance, 
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individuals often demonstrate preserved ability on some 
domains but impaired performance on others depending on the 
site of the infarct or infarcts (Coffey & Cummings, 1994).  
Unlike Alzheimer’s disease, the onset of cognitive 
impairment is often abrupt and a “stepwise” decline in 
cognitive functioning is typically observed as the disease 
progresses, with each step representing the occurrence of 
another vascular event.  VD usually affects people between 
the ages of 60 and 75 years and is slightly more common in 
men than women (Alexopoulos, 2003).  Individuals who have 
had a stroke are at increased risk for vascular dementia.  
In fact, researchers have demonstrated that the prevalence 
of dementia is nine times greater in patients who have had 
a stroke than in controls.  One year after a stroke, 
approximately 25% of patients develop new onset dementia.  
Within four years following a stroke, the relative risk of 
incident dementia is 5.5 times more likely for these 
individuals than for persons who do not have a history of 
stroke  (Madureira, Guerreiro, & Ferro, 2001).   
Frontal Lobe Dementia   
Frontal Lobe Dementia (FLD) is the name given to any 
dementia caused by damage to the frontal lobe portion of 
the brain.  This part of the brain is known to govern mood, 
behavior, judgment, and self-control. FLD includes Pick’s 
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disease, but can be caused by other disorders.  Like 
Alzheimer’s disease, Pick’s disease dementia causes a 
progressive and irreversible decline in a person’s 
abilities (Litvan, 2001).  From the onset of the disease, 
life expectancy is 2 to 15 years, with an average of 6 to 
12 years.  The first symptoms are typically psychological 
and behavioral problems.  In fact, the diagnosis is often 
suspected to be a psychiatric illness.  Individuals with 
FLD demonstrate deterioration of social skills and changes 
in personality early in the course of the illness yet they 
lack insight into the effects of their behaviors (e.g., 
show insensitivity to others, emotional blunting, 
behavioral disinhibition) (Kertesz, 2000).  The individual 
often becomes “obsessional” in these early stages, 
repeatedly washing hands, observing little rituals, or 
insisting that everything is in order (Worthington, 1996).  
FLD is also characterized by prominent language 
abnormalities.  For instance, the individual may begin 
using pat phrases repeatedly and excessively, lack 
spontaneous speech, and demonstrate a decrease in 
vocabulary.  Eventually, the individual’s dialogue is 
unintelligible and they may become completely mute by the 
end of the disease (Hodges, 2001). 
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Pick’s Disease can affect both men and women and it 
typically begins affecting people between 40 and 65 years 
of age (Riley, 1999).  As with Alzheimer’s disease, the 
cause cannot be determined in most cases; however there are 
strong genetic components in certain families.  A mutation 
on chromosome 17 has been identified and this genetic 
component has been described as affecting 20 to 50% of 
people with Pick’s disease (Bird, 1998).    
Subcortical Dementias   
The subcortical dementias are a group of disorders 
characterized by primary dysfunction in the subcortical 
areas of the brain.  These dementing conditions lead to 
motor dysfunction, speech impairment, memory dysfunction, 
executive disorders, and disturbances in mood and 
personality (Markesberry, ed., 1998).  Subcortical dementia 
occurs with extrapyramidal syndromes such as Parkinson’s 
disease, Wilson’s disease, progressive supranuclear palsy, 
and Huntington’s disease.  Although there is often a 
general decline in intellectual processes over time, this 
decline is usually much less severe than in other dementing 
disorders.  Parkinson’s and Huntington’s diseases will be 
briefly described. 
Parkinson’s Disease.  Parkinson’s disease is a slow, 
progressive neurological condition characterized by tremor, 
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rigidity, bradykinesia, and postural instability.  Dementia 
is noted in 20 to 60% of these cases (Aarsland et al., 
2001).  Cognitive and motoric slowing, executive 
dysfunction, and impairment in memory retrieval that is 
often exacerbated by depression characterize dementia 
associated with this disease (Ebmeier, Calder, Crawford, & 
Stewart, 1990). 
Huntington’s Disease.  Huntington’s disease is an 
inherited, progressive, degenerative disease of cognition, 
emotion, and movement.  This condition is usually diagnosed 
in the late 30’s or early 40’s but may begin as early as 
age 4 or as late as age 85.  Onset is often noted to have 
changes in behavior and personality (inclusive of 
depression, irritability, and anxiety).  Some individuals 
present with abnormalities of movement that resemble 
increased fidgeting and later progress to the 
characteristic “generalized choreothatosis”.  Difficulty 
with memory retrieval, executive functioning, and judgment 
are common (Paulsen et al., 2001).  Disorganized speech and 
psychotic features are sometimes present.  Late in the 
disease, marked ventricular dilation consistent with 
advanced cerebral atrophy (a.k.a., “boxcar ventricles”) may 
be seen on structural brain imaging. 
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Clinical Evaluation of Dementia 
 For a diagnosis of dementia, current criteria in the 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV), require evidence of decline from 
previous levels of functioning and impairment in multiple 
cognitive domains, not solely memory (APA, 1994).  In order 
to do this, clinicians have used a combination of clinical 
interviews, medical evaluations, and neuropsychology 
measures to detect cognitive and memory changes within the 
general population.  These methods will be discussed next.   
Clinical Interview  
A person’s medical and psychosocial history is an 
important part of the dementia evaluation.  Taking a 
thorough history involves gathering information from the 
individual, as well as the person’s family members and 
friends. Careful questioning is required to elicit clues to 
the presence of functional and cognitive impairment 
(Zelinski, Gilewski & Schaie, 1993). Questions should be 
asked about forgetfulness and orientation. Information 
about the individual’s daily functioning should also be 
obtained. For example, it is important to ask questions 
about the individual’s ability to do activities like take 
care of their hygiene, prepare meals, pay bills, remember 
appointments, take medications, and travel out of the 
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neighborhood (APA Presidential Task Force, 1997). An 
informant can be very helpful in providing information 
about the person's symptoms, such as when the symptoms were 
first noticed, how quickly they developed, and whether they 
have continued to get worse. The interview must review the 
individual’s past medical, social, educational, and 
vocational histories; whether there is a history of 
dementia in the family; and whether there have been any 
recent unusual events in the person's life.  Any 
significant exposure to alcohol, medications, and other 
possible toxins must also be considered (Brooke, 2002). 
Physical Exam and Laboratory Results  
Current DSM-IV criteria require evidence of impairment 
that interferes with the person’s previous level of social 
and occupational functioning.  However, because medications 
and various medical disorders may have adverse effects on 
an individual’s baseline functioning, a thorough assessment 
for chronic disease processes and a medication review is 
necessary to rule out specific treatable causes of 
dementia. Disorders found to cause symptoms of dementia 
include hearing or vision deficits, hypothyroidism, vitamin 
B12 deficiency and depression (Rogan & Lippa, 2002). These 
disorders are relatively easy to detect therefore 
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appropriate laboratory tests, physical examinations, and 
psychological tests should be administered.    
Laboratory tests recommended for the diagnostic work-
up of dementia include a complete blood cell count (to 
exclude anemia and infection) and urinalysis (to exclude 
infection). Serum electrolyte, glucose and calcium levels, 
blood urea nitrogen, serum creatinine level and liver 
function tests should also be done to investigate metabolic 
disease (Quality Standards Subcommittee, 1994). Syphilis 
serology, erythrocyte sedimentation rate, serum folate 
level, human immunodeficiency virus (HIV) status, urine 
check for heavy metals and toxicology screening may be 
indicated in a minority of cases (Rabins, Lyketsos & 
Steele, 1999).  Lumbar puncture is usually not necessary 
except when the onset of dementia occurs before 55 years of 
age or when a specific condition such as infection, 
syphilis or vasculitis is suspected (Quality Standards 
Subcommittee, 1994). The physical examination should also 
include assessment of cognitive domains, including speech 
(aphasia), motor memory (apraxia), sensory recognition 
(agnosia) and complex behavior sequencing (executive  
functioning) (Kramer & Duffy, 1996). This often requires 
referral for neuropsychological assessment (Drane & Osato, 
1997). 
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Aphasia is a disorder that results from damage to 
language centers of the brain.  It can also occur with 
damage to the connections between centers of transcortical 
aphasia.  Some individuals with aphasia have difficulty 
with expressive language (what is said) while others have 
problems with receptive language (what is understood).  
Language can be affected not only in its oral form (talking 
and comprehending) but also in its written form (reading 
and writing).  Word finding problems (dysnomia/anomia) are 
common in people with aphasia.  Asking the individual to 
name body parts or objects in the room may informally 
assess aphasia. Frequent use of vague terms such as "thing" 
and "it" may also signify deterioration of language 
function (Kertesz, 1994).  
Apraxia is a motor disorder of action planning in 
which volitional or voluntary movement is impaired without 
muscle weakness.  Heilman, Watson and Rothi (2000) defined 
apraxia as a disorder of skilled movement not caused by 
weakness, akinesia, deafferentation, abnormal tone or 
posture, movement disorders such as tremors or chorea, poor 
comprehension, or uncooperativeness.  An example of a test 
for apraxia is to ask the patient to pantomime the use of a 
common object such as a hammer or a toothbrush (Taylor, 
1994).  
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Agnosia is defined as the loss of ability to perceive 
or recognize sensory stimuli (i.e., objects, people, 
sounds, shapes or smells).  One way to assess for agnosia 
is by first asking the patient to close his or her eyes and 
then placing an object, such as a key or a coin, in the 
patient's hand and asking the patient to identify it 
without looking at it. Ringing a bell or honking a horn can 
evaluate auditory agnosia.  Asking the individual to 
identify a common scent (i.e., vanilla or lemon) can test 
olfactory agnosia.  Inability to recognize a common object 
despite normal sensory thresholds signifies agnosia (Kramer 
& Duffy, 1996).  
Osborn (1998) defined executive functioning as the 
ability to organize thought and work, to create plans and 
successfully execute them, and to manage the administrative 
functions of one’s life.  Asking the patient to perform a 
series of simple tasks is a way to evaluate executive 
functioning. For example, the individual can be asked to 
sign a piece of paper, put the piece of paper in his or her 
right hand, fold it in half and put it on the floor. This 
task would be difficult for a person with impairment in the 
ability to plan, initiate, sequence and monitor complex 
behavior. Asking the person to perform serial subtraction 
of 7s (backward from 100 to 65), to spell the word "world" 
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backward and to produce verbal word lists, such as names of 
animals or items in a grocery store, are other ways to test 
executive functioning and abstract thinking.  
Neuropsychological Tests  
Neuropsychological tests are often administered to 
assess difficulties in attention span, perception, memory, 
problem solving, and social and language skills.  These 
tests are often used to screen for cognitive impairment 
that may be indicative of a dementing process.  An 
individual’s responses on a neuropsychological battery may 
also provide clues to the underlying cause of dementia. For 
example, Jefferson et al. (2002) found that individuals 
with Alzheimer’s disease showed differential impairment on 
the Mini Mental State Examination (MMSE) indices measuring 
orientation and memory when compared to individuals with 
ischemic vascular dementia (IVD) and Parkinson’s disease 
(PD).  The IVD and PD groups performed significantly worse 
than the persons with AD on the MMSE indices assessing 
working memory and motor/constructional functions.  The 
authors therefore concluded that these indices could assist 
clinicians in deriving important information regarding the 
etiology of a patient’s dementing illness. 
 Common neuropsychological tests used for the 
assessment of dementia include: Folstein’s Mini Mental 
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State Examination (1975), the Neurobehavioral Cognitive 
Status Examination (1989), and the Mattis Dementia Rating 
Scale (1976, 1988).  
The Mini Mental State Examination (MMSE; Folstein, 
1976) is a brief, quantitative measure that has been widely 
used for assessing cognitive mental status. This test can 
be used to screen for cognitive impairment, to estimate the 
severity of mental impairment at any given point in time, 
to follow the course of cognitive changes in an adult over 
time, and to document an individual’s response to 
treatment. The MMSE has demonstrated validity and 
reliability in psychiatric, geriatric, neurologic, and 
other medical populations (Mitrushina & Saltz, 1991; 
Tombaugh et al., 1996).  However, studies have shown that 
it has limited specificity with respect to individual 
clinical syndromes (e.g., dementia or delirium) (Kirby et 
al., 2001; Tierney et al., 1997; Sabe, Jason, Juejati, & 
Leiguarda, 1993).  The test assesses orientation, 
attention, immediate and short-term recall, language, and 
the ability to follow simple verbal and written commands. 
Furthermore, it provides a total score that places the 
individual on a scale of cognitive function.  The maximum 
MMSE score is 30 points, individuals with a score of 23 may 
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be experiencing dementia (Sabe, Jason, Juejati, & 
Leiguarda, 1993). 
 The Neurobehavioral Cognitive Status Examination (CSE; 
1989) is a standardized test instrument for assessing 
cognition. It is designed to rapidly assess intellectual 
functioning in five major areas: language, constructional 
ability, memory, calculation skills, and 
reasoning/judgment. Three general factors are also 
examined: level of consciousness, attention, and 
orientation. The test requires less than 5 minutes to 
administer to individuals with “normal” functioning, and 
10-20 minutes for those who are impaired. The NCSE can be 
compared to the Mini-Mental State Exam (MMSE).   Studies 
investigating the reliability of the NCSE demonstrate good 
test-retest reliability, but poor inter-rater reliability 
(Lamarre & Patten, 1994). Few independent validation 
studies are available for this instrument.  Drane and Osato 
(1997) found the NCSE can be used to successfully identify 
cognitive dysfunction in all patients with a diagnosis of 
dementia (high sensitivity) but there were major problems 
with the specificity of the test.  The researchers found 
the NCSE to generate an unacceptable level of false 
positives among the healthy older adults (70%).  Therefore, 
 29
this test should not be used alone as a screening 
instrument for dementia. 
 The Dementia Rating Scale (DRS; Mattis, 1976, 1988) is 
a well-known and widely used instrument for assessing 
dementia.  It consists of five subscales that evaluate 
attention, perseveration and initiation, construction, 
memory, and conceptualization.  The DRS is composed of 
simpler items than traditional cognitive tests, thus 
decreasing its susceptibility to floor effects and 
increasing its sensitivity to individuals with substantial 
cognitive defects (Marson, Dymek, Duke, & Harrell, 1997).  
It is brief and easy to administer, typically taking 
between 20 to 40 minutes. Researchers have demonstrated 
that that the scale has excellent test-retest and inter-
consistency reliability (Vitaliano et al., 1984) as well as 
construct and criterion related validity (Vitaliano et al., 
1984; Vitaliano, Russo, & Breen, 1986).  The DRS total 
score also appears to validly quantify cognitive impairment 
for individuals with dementia (Moss & Alberts, 1988; Shay 
et al., 1991).  The DRS also can be used to track changes 
in cognitive status over time. 
The Assessment of Dementia among Persons with MR 
The standard clinical criteria for diagnosing dementia 
may be inadequate for assessing individuals with 
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developmental disabilities.  Often, individuals with MR do 
not present the traditional clinical signs of dementia 
(i.e., cognitive deterioration) or these signs may be 
difficult to detect (Menolascino & Potter, 1989).  For 
instance, individuals with developmental disabilities often 
demonstrate cognitive deficits such as memory impairment, 
receptive/expressive communication delays, and executive 
functioning disturbances at an early age. The mere presence 
of these cognitive deficits does not equate to a diagnosis 
of dementia because these impairments may have been present 
throughout the persons’ life (Haveman et al., 1994).  
Therefore, in persons with mental retardation, a 
diagnosis of dementia should be made based on a change in 
status from their baseline functioning (Aylward, Burt & 
Thorpe, 1997). For instance, the cognitive decline must 
interfere with the individual’s previous level of social or 
occupational functioning. Because evidence of decline in 
previous abilities is necessary, a personal knowledge of 
the individual is invaluable to the clinician to establish 
a diagnosis. Unfortunately, because individuals with MR 
often have poor to no communication skills and loss of 
speech is a common behavioral symptom of dementia, use of 
self-report methods is often impossible (Aylward, Burt & 
Thorpe, 1997).  Impairments in verbal skills make it 
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difficult for many individuals with developmental 
disabilities to articulate abstract or global concepts such 
as confusion and disorganized mental abilities.  According 
to Haveman et al.’s (1994) study, approximately 12% of 
residents in a large-scale residential facility in the 
Netherlands could not express themselves verbally and 
showed no signs of comprehension.  Another 27% were very 
restricted in their communication skills.   
Self report may be inappropriate for even those 
individuals with intact expressive language skills because 
researchers have demonstrated that often, as dementia 
becomes more severe, patients become less aware of their 
memory impairment (McDaniel et al., 1995).  Therefore, a 
caregiver’s report may be more accurate than information 
obtained from the individual.  Sevush (1999) found that 
caregivers’ evaluation of the patients’ memory had better 
associations with the patients’ dementia status and tested 
cognitive performance than the patients’ own evaluation. 
Therefore, an alternative to self-report is the use of 
caregiver interviews and informant questionnaires (Zelinski 
& Gilewski, 1988).  Standardized instruments that have been 
found to be useful for eliciting information from 
caregivers include the Dementia Questionnaire for Mentally 
Retarded Persons (DMR; Evenhuis, Kengen, & Eurlings, 1990; 
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Evenhuis, 1992, 1996), the Dementia Scale for Down’s 
Syndrome (DSDS; Gedye, 1995), and the Early Signs of 
Dementia Checklist (Visser & Kuilman, 1990). 
These interviews should be completed with individuals 
who are familiar with the person’s everyday behavior 
(Gedye, 1995).  The informants should know the person well 
and have a significant amount of contact with him/her.  
Someone who was familiar with the person prior to the 
dementing process is always preferable.  This method allows 
the clinician to establish the symptoms’ mode of onset 
(abrupt versus gradual), progression (stepwise versus 
continuous decline, worsening versus fluctuating versus 
improving), and duration.  This retrospective information 
is also critical to determine whether there has been a 
change in baseline functioning.  When the individual lives 
in an institution or group home with multiple caregivers, 
it is recommended that multiple informants be interviewed 
(Gedye, 1998).   
Information from individuals familiar with the patient 
is beneficial but caregiver reports should not be the only 
source of data.  Researchers have found that there are 
often incongruencies between caregiver reports and 
objective test measures, with some informants over-
reporting the severity of symptoms and others under-
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reporting impairment.  Prosch-Huy (2001) found significant 
differences between informant reports and scores on the 
Folstein Mini Mental State Exam (MMSE), with impairment 
appearing more severe when measured by MMSE than caregiver 
report. In contrast, DeBettignies, Mahurin, and Pirozzolo 
(1993) found that caregivers of adults with Alzheimer’s 
disease rated the patients as being more functionally 
impaired than what was revealed by actual performance 
testing.   
Because informant reports may be unreliable and 
inconsistent and retrospective reports may be flawed 
(especially reports about memory or cognitive functioning), 
direct assessment of the individual is critical to 
supplement information supplied by caregivers.  The most 
objective way to measure changes in cognitive and adaptive 
functioning is the longitudinal administration of tests 
that assess level of impairment (Aylward, Burt, Thorpe, 
Lia, & Dalton, 1995).  In order to do this; the Working 
Group for the Establishment of Criteria for the Diagnosis 
of Dementia in Individuals with Intellectual Disabilities 
recommended that all adults with mental retardation undergo 
a comprehensive evaluation (i.e., intellectual assessment, 
evaluation of adaptive functioning, assessment of 
psychopathology, and mental status exam) at least once by 
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the age of 25 years (Aylward et al., 1995).  This allows 
the clinician to establish a record of baseline functioning 
(Burt & Aylward, 1999). 
Cognitive Assessment 
Standardized, individually administered intelligence 
tests are the most important instruments used to diagnose 
mental retardation (Sattler, 1992).  These tests can also 
be used to track changes in cognitive abilities by 
comparing the individual’s performance over time.  
Unfortunately, dementing processes are often difficult to 
identify among persons with intellectual disabilities 
because subsequent cognitive impairments can be 
indiscernible (Shultz et al., 1998).  Current standardized 
measures of intellectual functioning may be uninformative, 
especially in people with very low IQ, as the score may 
already be so low that no changes are observed with a 
further dementing process (Janicki, Heller, Seltzer, & 
Hogg, 1996).  Dalton, Seltzer, Adlin, and Wisniewski (1993) 
attempted to detect cognitive deficits indicative of 
dementia in persons with Down syndrome.  They found that 
commonly used instruments for assessing cognitive 
functioning are unreliable in persons with lower cognitive 
abilities.  These measures are often insensitive at the 
lower end of the cognitive spectrum often causing 
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individuals with MR to score very poorly due to the so 
called “floor effect” (Sattler, 1988). 
Additionally, many of the mental status exams that are 
used to evaluate dementia in the general population are not 
appropriate for use with persons with mental retardation.  
The mental status exams were designed for individuals whose 
previous level of cognitive functioning was assumed to be 
normal (Aylward et al., 1995).  Researchers have noted that 
people who demonstrate “below average” performance on 
intelligence tests often perform poorly on tests of mental 
status.  These individuals are likely to be labeled 
“cognitively declined” because of biases built into the 
measures rather than due to true decline (Shultz, Aman & 
Rojahn, 1998; Zelinski & Gilewski, 1988).  Several mental 
status examinations have been developed or adapted for use 
with persons with developmental disabilities.  These 
include the Down’s Syndrome Mental Status Examination 
(DSMSE) and the Test of Severe Impairment (TSI).  The DSMSE 
(Haxby, 1989) consists of a battery of neuropsychological 
tests assessing a broad range of skills, including recall 
of personal information, orientation to season and day of 
the week, memory, language, visual-spatial function and 
praxis.  The TSI (Albert & Cohen, 1992) also covers a broad 
range of cognitive functions, including motor performance, 
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language comprehension, language production, immediate and 
delayed memory, general knowledge and conceptualization.  
These tests can be repeated periodically to compare results 
over time. 
Non-Cognitive Assessment 
Because cognitive changes are often not readily 
discernable, clinicians often rely on behavioral symptoms 
to determine a diagnosis of dementia.  In fact, these “non-
cognitive” aspects of dementia are often the first signs 
reported in individuals with MR (Cooper & Prasher, 1998; 
Evenhuis, 1990; Janicki et al., 1992). Behavioral changes 
such as irritability, increased wandering, sleep 
difficulty, urinary incontinence, loss of interest and 
anhedonia have been related to the development of dementia 
in persons with MR (Janicki et al., 1995; Prasher, 
Krishnan, & Clarke, 1994).  Other behavioral symptoms that 
may be indicative of dementia include changes from 
previously higher levels of adaptive functioning, loss of 
speech, seizures in previously unaffected individuals, 
disorientation, and increase in stereotyped behavior 
(Aitken, Simpson & Burns, 1999; Bozzola, Gorelick, & Freels 
et al., 1992; Cummings et al., 1994; Janicki et al., 1995).  
The challenging behaviors displayed by older adults with 
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dementia may be separated into two categories: behavioral 
deficits and behavioral excesses (Burgio, 1996).   
Behavioral deficits, wherein the non-occurrence of a 
behavior constitutes a problem, are key defining 
characteristics of mental retardation.  These deficits may 
have been noted in functional and social domains since 
childhood (Aylward et al., 1995).  However, individuals 
with mental retardation may present with further decline as 
they age (e.g., lose ability to perform daily living skills 
that were previously mastered, become less verbal, and 
limit social interaction).  Declines in social and adaptive 
functioning beyond baseline levels are a cardinal 
diagnostic feature of dementia (Shultz, Aman & Rojahn, 
1998).   
Although some decline in adaptive functioning is 
expected as an effect of normal aging, decline in the 
ability to perform activities of daily living is even more 
pronounced among individuals with dementia.  For instance, 
Zigman et al. (1994) found the level of adaptive 
functioning significantly decreased in individuals with 
Down’s syndrome aged 50 years and older.  Schupf, Lubin and 
Silverman (1987) analyzed records of 2144 individuals with 
Down’s syndrome and of 4172 controls diagnosed with mental 
retardation of other etiology.  They found that adaptive 
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competence declined with increasing age to a greater extent 
for individuals with Down’s syndrome than for controls with 
other intellectual disabilities.  The declines noted by 
Zigman et al. (1994) and Schupf and associates (1987) is 
presumably attributed to the presence of dementia among 
aging persons with Down’s syndrome.  It is known that all 
individuals with Down’s syndrome develop the characteristic 
neuropathological brain lesions of Alzheimer’s disease 
(i.e., neuritic plaques, granulo-vacuolar changes, cerebral 
vascular amyloidosis, Hirano bodies and neurofibrillary 
tangles) by the age of 40 years (Lai & Williams, 1989). 
Individuals with Down’s syndrome are not the only 
individuals who present with declines in adaptive behavior. 
Draper et al. (2000) found that subjects with dementia had 
greater functional impairments than controls.  For 
instance, individuals with dementia participated in less 
social activities.  Norbergh et al. (2001) investigated the 
activity of demented patients at a psycho-geriatric unit.  
The findings showed that persons with dementia who reside 
in an institution often experience lives of solitude.  
Armstrong-Esther and Brown (1996) found similar results 
among patients in a geriatric ward where the individuals 
spent 88.5% of their time alone.  Low social engagement, 
decreased initiation and lack of interest are common 
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behavioral symptoms associated with dementia.  Apathy, 
which broadly defines these symptoms, occurs in up to 92% 
of individuals diagnosed with dementia (Mega et al., 1996).   
Researchers have also found that the presence of 
dementia has dramatic impact on one's communication skills.  
Draper and colleagues (2000) found that expressive 
communication skills were significantly more impaired in 
persons with dementia with only 40% being able to 
communicate “well enough most times” as compared to 80% of 
controls.  One’s ability to communicate effectively is very 
important.  It influences an individual’s capacity to 
perform daily living skills, their ability to get their 
needs met, and has dramatic impact on a person’s social 
interactions.  Researchers have demonstrated that nursing 
home staff interact more with individuals who can 
communicate.  For instance, Elkman et al. (1991) found that 
caregivers seldom go to demented patients who have 
communication problems just to talk to them, and that less 
time is spent with those individuals during the various 
care activities.   
Although individuals with dementia often present with 
loss of speech, vocally disruptive behavior, in addition to 
physical aggression, is one of the most challenging 
behaviors for nursing home staff to manage (Everitt et al., 
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1991; Whall et al., 1992).  Disruptive vocalizations 
include loud requests for attention, chronic screaming, 
self-talk, negative remarks, and use of obscenities 
(Vaccaro, 1990).  Physically aggressive behaviors include 
pushing, spitting, grabbing, kicking, hitting, and other 
dangerous, assaultive behaviors (Cohen-Mansfield, 1989).  
Rosen et al. (1994) reported that verbal and physical 
aggression occurred in approximately 80% of nursing home 
residents diagnosed with dementia. Physical aggression is 
more common among moderately to severely demented 
individuals and occurs most often during daily care 
routines (Hoeffer et al., 1997).  These maladaptive 
behaviors are often referred to as behavioral excesses 
because the occurrence of these behaviors constitutes the 
problem (Cohen-Mansfield et al., 1989).   
The main factors that seem to contribute to vocally 
disruptive and physically aggressive behavior are severe 
impairment in the performance of daily living skills, pain, 
and communication difficulties (Cohen-Mansfield & Werner, 
1997).  If we interpret this from a functional standpoint, 
all behaviors serve a communicative purpose. Individuals 
with dementia who are no longer able to express themselves 
with language may use disruptive behavior to reflect an 
underlying need or discomfort, or a response to 
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environmental or physical stimuli.  Researchers have 
demonstrated that staff members’ responses to these 
behaviors often inadvertently reward the individual, 
thereby increasing or maintaining the current rate of 
aggressive and/or disruptive behavior (Vaccaro, 1990).  For 
instance, staff members may provide the individual with 
either positive or negative attention (i.e., comforting the 
person or attempting to stop the behavior through loud 
verbal reprimands). Parenthetically, even negative 
attention is rewarding to someone whose schedule of 
reinforcement is really lean.   
Other symptom clusters that are common among persons 
diagnosed with dementia are “psychosis” (hallucinations, 
delusions, paranoia), “depression” (sad appearance, crying, 
guilt, anxiety), and “motor hyperactivity or psychomotor 
agitation” (pacing, aimless walking, handling objects 
inappropriately) (Aitkin, Simpson & Burns, 1999).  These 
“non-cognitive” symptoms are commonly associated with the 
degenerative changes of dementia and they are often the 
first or only identifiable signs of dementia in persons 
with developmental disabilities (Moss & Patel, 1995). These  
behavioral challenges often increase in severity and 
frequency as the dementia progresses (Cooper et al., 1990; 
Jacomb et al., 1994). 
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Rationale and Purpose 
Short of autopsy, there are no conclusive biological 
markers for the most common forms of dementia (Rogan & 
Lippa, 2002).  Therefore, diagnosis is often based on 
objective longitudinal evidence of deterioration of 
cognitive abilities and evidence of deterioration in 
adaptive behavior and/or social skills especially in 
persons with MR (Aylward et al., 1995).  Although these 
longitudinal changes are essential to diagnose dementia 
(APA, 1994), groups of investigators have, to some extent, 
developed their own classification methods (Aylward, Burt & 
Thorpe, 1997; Barcikowska, Silverman & Zigman, 1989; Burt & 
Aylward, 1999; Janicki, Heller & Hogg, 1996; Prasher, 
Krishnan & Clarke, 1994; Shultz, Aman, & Rojahn, 1998; 
Silverman et al, 1998; Visser & Kuilman, 1990; Visser et 
al., 1997).  Although these approaches share some 
commonalities (e.g., investigating decline in functioning, 
comparison between identified “dementia” and “non-dementia” 
groups) they differ in their emphasis on different types of 
data (e.g., use of various adaptive behavior measures, 
mental status examinations, cognitive assessments, scales 
of psychopathology, and caregiver reports) and analysis 
(e.g., cross-sectional designs, longitudinal studies). 
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Burt and Aylward (2000) considered a working battery 
of tests for the diagnosis of dementia among persons with 
intellectual disabilities.  The battery is divided into two 
parts: administration of informant-report scales and direct 
assessment of the individual with MR (Aylward et al., 
1997).  Administration of six informant report scales is 
recommended.  These include the Dementia Questionnaire for 
Mentally Retarded Persons, the Dementia Scale for Down 
Syndrome, the Reiss Screen for Maladaptive Behavior, the 
Scales of Independent Behavior – Revised, the AAMR Adaptive 
Behavior Scale – Residential and Community (2nd Ed.), and 
the Stress Index (Burt & Aylward, 2000).  The 
administration time for each of these scales varies (i.e., 
according to their respective manuals, the AAMR Adaptive 
Behavior Scale takes approximately 30 minutes to administer 
(Nihira, Leland & Lambert, 1993) and the Scales of 
Independent Behavior – R (Bruinink, Woodcock, Weatherman & 
Hill, 1996) takes approximately 60 minutes).  
Administration is manageable when one or two of these 
scales are used; however, administration of all six scales 
is quite time-consuming.  Burt and Aylward (2000) also 
selected 10 instruments to be administered directly to the 
individual with MR (the Test for Severe Impairment, 
Stanford Binet Sentences, the Fuld (modified), 
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Autobiographical Memory, Orientation, the Boston Naming 
Test, the McCarthy Verbal Fluency, Simple Commands, the 
Purdue Pegboard (modified), and the Developmental Test of 
Visual Motor Integration).  The researchers noted that all 
of the tests have the capacity to assess individuals with 
MR ranging from mild to profound levels but this statement 
can be disputed.  For example, several tests recommended 
are inappropriate for individuals with limited to no verbal 
skills.  According to “administration notes” provided by 
Burt and Aylward (2000), four of the ten instruments 
require “speech which is clear enough to score.”  Also, 
persons with receptive language deficits may have 
difficulty comprehending task instructions.  Persons with 
fine motor difficulties are likely to perform poorly on 
three instruments that require manipulation of small 
objects and the ability to maneuver a pencil across paper.  
In addition, it is likely that individuals with short 
attention spans would have difficulty completing the 
battery in a single sitting therefore multiple sessions 
would be required.  Fatigue and frustration would also make 
completion of the battery challenging.  Therefore, it is 
believed that though these instruments may be effective in 
assessing dementia among individuals with mild and moderate 
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MR, use with persons with severe and profound MR is 
dubious. 
Visser et al. (1997) also proposed a method to detect 
dementia in individuals with Down’s syndrome.  Visser et 
al.’s (1997) clinical diagnosis of dementia is based on 
specific clinical symptoms, changes in social skills, and 
changes in the background alpha rhythm measured by the EEG. 
The researchers categorized 307 participants into five 
groups based on the participant’s performance on the Early 
Signs of Dementia Checklist (ESDC, Visser & Kuilman, 1990), 
scores on the Social Skills Inventory for the Mentally 
Retarded (Sociale Redzaambeids-shaalvoor Zwakzinnigan; 
Kraijer & Kema, 1981) and EEG recordings as follows: Group 
1 = no deterioration, Group 2 = onset of deterioration, 
Group 3 = distinct behavioral change, Group 4 = advanced 
dementia and Group 5 = time of complete dependency. Visser 
et al. (1997) established the validity of this method by 
comparing their clinical findings with postmortem 
neuropathological findings. Permission was obtained to 
perform an autopsy on 16 patients who died during the 
course of the study (13 identified with clinical dementia, 
3 did not meet Visser et al. (1997) criteria for dementia).  
A very strong correlation was found.  The 13 patients who 
were clinically diagnosed as having dementia using their 
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method also presented with brain changes consistent with 
severe forms of Alzheimer’s disease.  For instance, senile 
plaques, neurofibrillary degeneration at the frontal and 
temporal cortices, severely disrupted interneuronal 
networks, and neurofibrillary degeneration in the 
parahippocampal gyrus and the hippocampus were found.  
Neuroanatomic evidence of Alzheimer disease was not in the 
autopsy findings in the three other deceased participants 
who did not meet clinical criteria of dementia.   
One particular advantage of the Visser et al. (1997) 
model is its suitability for use on individuals who have a 
low level of intellectual functioning.  The collection of 
information about aspects of cognitive functioning is not 
time consuming and the measures were found to be patient-
friendly because they do not involve assessment interaction 
with the individuals.  Another advantage is the converging 
vectors looking at resident behavior via serial evaluations 
of participants, caregiver reports with the Early Signs of 
Dementia Checklist, and the physiological exam findings 
with the EEG.  When all three of these vectors converge, 
good confidence can be placed in the clinical diagnosis of 
dementia. 
The purpose of this present study was to apply Visser 
et al.’s (1997) model to determine whether it could detect 
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dementia among persons diagnosed with severe or profound 
mental retardation using a social skills measure in common 
use in facilities in the U.S.  The primary reason for 
focusing on this group of individuals is because persons 
with severe and profound mental retardation demonstrate the 
greatest communication deficits and lowest baseline 
abilities thereby making the identification of dementia 
based on standard methods such as cognitive assessments and 
mental status exams quite difficult.  This study is more 
than just a replication of Visser et al.’s research as 
individuals with and without Down’s syndrome were sampled.  
Much of the research on dementia among persons with MR has 
been conducted with individuals with Down’s syndrome.  It 
is felt that additional studies need to be conducted 
comparing the prevalence and course of dementia among 
persons with and without Down’s syndrome. In addition, the 
Matson Evaluation of Social Skills in Individuals with 
Severe Retardation (MESSIER; Matson, 1995) was used rather 
than the Social Skills Inventory for the Mentally Retarded.  
The Social Skills Inventory for the Mentally Retarded does 
not have an English-version.  Several steps would need to 
be completed before use of this measure would be 
appropriate in the United States (e.g., translation, 
cultural adaptation, validation for use in the U.S., 
 48
assessment of the psychometric equivalencies across English 
and Dutch versions).  This process is very time consuming 
and can be avoided if it can be validly replaced with 
another well established measure that assesses social 
skills in individuals with MR. The MESSIER was chosen 
because it has demonstrated itself to be a reliable and 
valid measure of social skills in persons with severe and 
profound MR in the United States. 
Visser et al. (1997) were able to gather neuroanatomic 
evidence of Alzheimer’s disease on 13 participants who died 
during the course of their study.  However, postmortem 
neurological assessments were excluded from this present 
investigation.  Therefore, because of the problem of making 
an ironclad determination of dementia without evidence of 
deterioration of brain tissue, a differential prevalence 
design was used.  Differential prevalence designs are often 
used in research to distinguish malingerers from non-
malingerers.  This group is another for whom diagnostic 
confirmations are extraordinarily difficult to obtain.  
Research on malingering often involves groups of people 
claiming brain dysfunction who are in litigation with 
groups of people claiming brain dysfunction who are not in 
litigation, under the assumption those who are in 
litigation may be malingering and those who are not in 
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litigation are not (Greve et al., 2003).  Differential 
prevalence designs are not a guarantee of true assignment.  
For instance, some individuals grouped as “non-malingering” 
may indeed be malingering and some grouped as malingerers 
may be truthful.  The problem is that there is no “gold 
standard” and assignment to “known groups” is only possible 
if a malingerer is “caught”.  Researchers also believe that 
those caught do not represent the true population of 
malingerers.  Rather, they likely represent unsophisticated 
malingerers who are easy to detect (Millis, Ross & Ricker, 
1998).  Using a differential prevalence design for this 
particular study enables us to compare three groups of 
individuals who vary in risk for dementia. 
Validating Visser et al.’s (1997) method on an 
American sample is important in light of the dramatic 
increase of the elderly population of adults with MR in the 
United States (persons susceptible to dementing processes) 
and the increased interest in the accurate detection of 
dementia in persons with developmental disabilities.  Early 
detection is important because there are numerous reports 
in which the course of dementia can be arrested and in some 
cases even reversed. Thase (1982) reported a case of 
reversible dementia secondary to hypothyroidism.  A 
complete psychological/physical assessment indicated 
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dementia secondary to low thyroid functioning.  The patient 
fully recovered to premorbid functioning when the 
appropriate treatment was administered.  Gedye (1998) 
described four cases of neuroleptic induced dementia among 
individuals with intellectual disabilities.  These 
individuals returned to their previous functional states 
when the offending medications were discontinued.   
Early identification of dementia has important 
clinical implications because it can guide treatment 
planning and clinical care.  Clinicians can use this data 
to identify decline in previous capabilities and then 
intervene in order to retrain these skills or prevent 
further loss.  In addition, this data can be used to 
identify an individual’s spared abilities and treatment 
strategies can be designed to further tap into and take 
advantage of these facilities.  It is believed that good 
clinical data on the early signs and course of dementia 
will eventually result in a better outcome for aging 








 Hypothesis #1 - It was hypothesized that individuals 
who belonged to the “high risk” group would demonstrate 
fewer positive social skills (as evinced by low MESSIER 
Positive scores and high MESSIER Negative scores) and more 
characteristic symptoms of dementia (as noted by ESDC item 
endorsements) than persons in the “medium risk” and “low 
risk” groups.  Individuals identified as “medium risk” 
would perform worse on the MESSIER Positive and Negative 
scales and ESDC than persons in the “low risk” group. 
 Hypothesis #2 – It was hypothesized that individuals 
with Down’s syndrome would perform worse than persons 
without Down’s syndrome across the “high” and “medium risk” 
levels.  However, an interaction was predicted, in that 
Hypothesis #2 would not hold in the “low risk” group.  That 
is, young persons with and without Down’s syndrome would 
demonstrate little symptoms characteristic of dementia. 
 Hypothesis #3 – It was hypothesized that the rate of 
decline in social abilities would be greatest for 
participants with Down’s syndrome who had been identified 







Participants were 90 individuals residing at a large 
developmental center in Louisiana.  The sample size was 
based on results from an a priori power analysis with alpha 
= .05, power = .80 and the effect size = .30.  This effect 
size is based on an average of several effect sizes 
reported in dementia research (Burt et al., 1995; Prasher & 
Chung, 1996; Zigman et al., 2004).  All participants were 
classified, prior to the study, as having severe or 
profound mental retardation based on DSM-IV criteria (APA, 
1994).  Fifty-nine of the ninety participants (65.5%) were 
diagnosed with profound mental retardation. 
Using a differential prevalence design, participants 
were equivalently selected for assignment to one of three 
groups based on their perceived “risk for dementia”.  These 
groups were selected with the intention that assigning 
participants to three extreme groups would increase power 
and likely effect.  The high-risk group comprised of 30 
individuals who had been referred for psychological 
assessment in order to screen/rule out for dementia.  These 
individuals had been referred by direct care staff members 
or by psychology staff because of observed behavioral, 
cognitive, personality, or social skill changes.  No age 
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limitations were imposed on this group therefore 
individuals in the high-risk group ranged from 41 years to 
92 years, with a mean age of 57.1 years.  The medium risk 
group was made up of 30 “old age” individuals who had not 
been referred for evaluation.  “Old age” was defined as 
persons aged 55 years or older.  Age 55 was selected 
because researchers have generally defined “old age” in 
persons with MR as those individuals 55 years and older 
(Seltzer, 1992).  This age cut off seems arbitrary but the 
criteria are based on several factors including attempts to 
include some subgroups that seem to age prematurely (i.e., 
individuals with Down’s Syndrome and individuals with 
Cerebral Palsy), observations of changes of functions among 
individuals with MR, and expectations for change in normal 
age related activities (Seltzer, 1992; Seltzer & Krauss, 
1987).  These individuals represented the aging population 
of persons with MR who had not been referred by caretakers 
due to observed decline/change.  The mean age of the medium 
risk group was 59.9 years, with individuals ranging from 55 
to 68 years.  The low risk group was comprised of 30 
individuals aged 40 years or younger (mean age = 36.1) who 
had not been referred for a neuropsychological assessment.   
One half of the participants for each of the three 
risk groups were comprised of individuals who have Down’s 
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syndrome (DS) (n = 45).  Every Down’s syndrome subject was 
identified by their characteristic facial features and 




 High Risk Medium Risk Low Risk 
Down Syndrome n=15 n=15 n=15 
Non-DS n=15 n=15 n=15 
 
An attempt was made to match the groups on four 
factors: gender, level of mental retardation (severe or 
profound), other psychiatric diagnoses, and psychotropic 
medication.  It is important to match the individuals on 
“other psychiatric diagnoses” in order to confidently state 
that significant differences in scores on measures of 
social skills and current cognitive functioning are a 
factor of a dementing process rather than the person’s co-
morbid Axis I diagnosis.  Participants were matched on 
medication to minimize the possibility that loss of skills 
is due to medication side effects (i.e., lethargy, physical 
discomfort, etc.).   
Interviewers and Informants 
All interviewers were master’s level psychologists 
with training specific to the area of mental retardation.  
Interviewers were trained in the administration of the 
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assessment instruments by a licensed supervising 
psychologist or a trained doctoral student in clinical 
psychology, and had been employed at the developmental 
center for at least one month prior to conducting 
interviews.  Informants (the individual providing answers 
to the assessment questions) were direct support staff who 
had worked with the participants for a minimum of 12 
months.  All informants held the title of either home 
manager (charge staff) or group leader. 
Table 2 
Demographic Variables   
 Age MR Level Participants 








50.7 yrs Profound = 11 
Severe = 4 




63.5 yrs Profound = 11 




58.2 yrs Profound = 10 
Severe = 5 




61.6 yrs Profound = 9 




36.5 yrs Profound = 9 
Severe = 6 




35.7 yrs Profound = 9 




Matson Evaluation of Social Skills in Individuals with 
Severe Retardation. The Matson Evaluation of Social Skills 
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for Individuals with Severe Retardation (MESSIER; Matson, 
1995) was used as a measure of social skills.  The MESSIER 
was specifically designed to assess social skills in 
persons with severe and profound mental retardation.  It 
consists of 85 items generated from a review of existing 
social skills measures for children and adults, items from 
the social and communication domains of adaptive behavior 
scales, and items nominated by experts.  The items are 
grouped into six clinically derived subscales: 1) positive 
verbal, 2) positive non-verbal, 3) positive general, 4) 
negative verbal, 5) negative non-verbal, and 6) negative 
general.  Each item is rated on frequency using a four-
point Likert: never (0), rarely (1), sometimes (2), and 
often (3).  The MESSIER is administered by a trained 
examiner in a semi-structured interview format.  The 
respondent should be a caregiver who has worked with the 
individual for at least six months. 
 The psychometric properties of the MESSIER have been 
studied.  Internal consistence and test-retest reliability 
was high.  Good correlations were also found between raters 
for the total MESSIER score and for all positive and 
negative MESSIER items (Matson, LeBlanc, Weinheimer & 
Cherry, 1999).  The convergent validity of the MESSIER was 
evaluated by comparing it to the Socialization domain of 
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the VABS and sociometric ratings.  Significant positive 
correlations were found between corresponding MESSIER 
subscales and VABS subdomains on social behaviors. Although 
the MESSIER and VABS (Socialization domain) seem to measure 
similar constructs, the MESSIER was used in this study 
because it has several advantages over the VABS in 
measuring social skills in persons with severe and profound 
mental retardation.  First, the MESSIER has a large number 
of social skills specific questions than the VABS.  Second, 
the MESSIER can be used to illustrate an individual’s 
social skills and deficits, as well as maladaptive behavior 
excesses, whereas the VABS is limited to providing 
information about social abilities only.   
Early Signs of Dementia Checklist (ESDC; Visser & 
Kuilman, 1990).  The ESDC is a scale designed to assess for 
clinical signs of mental deterioration.  The instrument 
consists of 37 questions divided over 9 categories 
(General, Personality Changes, Decrease in Performance, 
Deterioration of Language Skills, Deterioration of Gait, 
Disorientation, Incontinence, Epilepsy, and Loss of School-
Acquired Skills).  These categories were selected to 
inquire about symptoms that have been found to occur with 
deterioration associated with dementia (Ballard et al., 
2001).  There are, however, some troublesome items that may 
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cause clinicians and researchers to over-predict dementia.  
For instance, items are endorsed if an individual is 
currently incontinent.  These endorsements may give the 
impression that deterioration has occurred (i.e., it may 
appear that an individuals who was able to toilet 
independently is now having toileting accidents).  However, 
it does not take into account that some persons with 
limited self-help skills may have never acquired self-
toileting skills and may have always relied on protective 
undergarments and caregiver assistance.  Therefore, items 
on the Incontinence section should be interpreted with 
caution.  It is suggested that items should only be 
endorsed if there is loss of continence (e.g., a change). 
The ESDC is completed via interview.  The interviewer 
should be a trained examiner familiar with the measure.  
The respondent should be a caregiver who is familiar with 
the individual and has worked directly with them for at 
least 6 months.  Each item is scored on a binomial scale 
(Yes- 1, No – 0). 
The ESDC has demonstrated good psychometric properties 
(internal consistency of 0.82 and an interrater reliability 
of about 0.80).  It has also shown to be effective to 
reliably detect Alzheimer-type dementia at an early stage 
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when combined with a social skills inventory and EEG 
(Visser et al., 1997). 
Procedure 
Retrospective data were utilized to ascertain decline 
in social skills.  This method was accomplished by 
conducting a chart review of the previous three annual 
psychological evaluations for each participant and noting 
the raw scores on the MESSIER Positive and MESSIER Negative 
scales.  Data systems had been set up at the developmental 
center several years ago with the intention of using the 
data for research.   
There was an approximate one-year interval between 
administrations of the MESSIER (mean period between 
administrations of the scale = 10.9 months).  This period 
was selected because, in most instances, a one-year follow-
up interval is adequate for monitoring changes in cognitive 
performance (APA Presidential Task Force, 1998).  Visser et 
al. (1997) noted that all their patients were in a 
prodromal phase that lasted on average 1.3 years in which 
the individuals showed aspecific clinical symptoms that 
heralded the later progressive deterioration.  The duration 
of the deterioration was considered to be the time between 
the onset of distinctive dementia and complete dependency.  
The mean duration of deterioration was 2.6 years.   
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Current testing was completed to collect information 
about the individual’s current functioning via interview 
with direct care staff using the Early Signs of Dementia 
Checklist (ESDC).  This measure was administered within 3 
months of the most recent MESSIER screening in order to 
limit the possibility of further changes in social skills 
between test administrations (mean period between 
administration of MESSIER and ESDC was 2.1 months).  The 
ESDC was used to get a picture of the clinical signs of the 
individual’s deterioration.  For this study, the items on 
the “Incontinence” section were modified to more accurately 
assess for observed changes in toileting skills.  This 
modification was done to control for persons who may have 
never acquired independent toileting.  The ESDC inquires 
whether the resident shows urinary incontinence during the 
day/night either occasionally or continuously and whether 
the resident shows fecal incontinence.  An individual who 
was never toilet trained may acquire points on the ESDC 
despite these symptoms being present since baseline and 
thus, not indicative of a deteriorating process.  
Therefore, when administering this section, the interviewer 
was first asked whether the resident was or ever had been 
able to independently toilet.  If the reply was “no”, the 




Following the example of Visser et al. (1997), 
participants were categorized into one of 5 groups using a 
cross tabulation procedure.  The purpose of this was to 
show in tabular format the relationship between the 5 
categorical values. Those individuals who did not show 
evidence of decline based on a score of 4 or less on the 
ESDC were labeled “non-deterioration” (N = 48).  A second 
category “onset of deterioration” was used to describe 
participants who had a score of 5 or higher on the ESDC but 
who did not show 25% deterioration in their social skills 
functioning (N = 27).  “Distinct behavioral change” was 
used to describe individuals who showed 25% deterioration 
in their positive social skills and a score of 10 or higher 
on the ESDC (N = 12).  “Advanced dementia” was used to 
categorize persons who showed 50% reduction in positive 
social skills and at least 10 ESDC symptoms (N = 3).  
Although some participants had minimal scores on the social 
skills measure (reflecting the near absence of positive 
social skills), none of the participants needed nursing 
care for all domains of daily functioning.  Therefore 
Visser et al.’s (1997) fifth category “complete dependency” 
was omitted from our analyses.   
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Next, participants in each of the four Visser et al. 
categories were sorted further based on their “risk of 
dementia” status.  Of the 48 participants categorized as 
“no deterioration”, 10 belonged to the high risk group, 15 
belonged to the medium risk group, and 23 belonged to the 
low risk group.  Of the 27 participants labeled as “onset 
of deterioration”, 11 were high risk, 10 were medium risk, 
and 6 were low risk.  Six high risk, 5 medium risk and 1 
low risk participant met criteria for “distinct behavior 
change”.  All 3 participants identified as “advanced 
dementia” belonged to the high risk group.   
Table 3 










10 11 6 3 
 
High Risk 
    
15 10 5 0 
 
Medium Risk 
    
Low Risk 23 6 1 0 
 
 
These data demonstrate that, as compared to the medium 
and low risk groups, individuals classified as high risk 
had the least number of participants meeting Visser et al. 
(1997) criteria for “no deterioration” but the greatest 
prevalence of individuals meeting criteria for “advanced 
dementia”.  Conversely, the low risk group had the greatest 
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number of participants in the “no deterioration” category 
and the least in the “distinct change” category. 
 
                                            Legend 
                                            ND = No Deterioration 
                                            OD = Onset of Deterioration 
                                            DC = Distinct Change 
                                            AD = Advanced Dementia 
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Figure 1 
Distribution of Dementia Category Frequencies 
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Though the cross tabulation graphs look different for 
the three risk referral groups, a hypothesis test was 
performed on the contingency table to determine whether or 
not dementia classification was distributed similarly 
across the different “risk of dementia” groups.  The 
observed frequencies were used to compute the expected 
frequencies for the four Visser et al. (1997) categories.  
It was determined that the expected count of individuals in 
each of the Visser et al. categories for the high, medium 
and low risk groups was as follows: “no deterioration” = 
16, “onset of deterioration” = 9, “distinct change” = 4, 
and “advanced dementia” = 1.  A chi square test compared 
the expected and the observed frequencies in each cell.  
Chi square is most frequently used to test the statistical 
significance of results reported in a contingency table 
(Brymer & Cramer, 2001)).  The computed chi square 
statistic (χ) of .012 was less than .05 indicating that 
assignment to the Visser et al. categories was not 
distributed similarly across the different levels of risk.  
The frequency of individuals meeting Visser et al. criteria 
for dementia classification was related to their perceived 
risk (e.g., individuals identified as high risk are more 
likely to meet Visser et al. criteria for dementia than 
individuals identified as low risk).   
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Cross Sectional Analyses 
A cross sectional analysis (multivariate analysis of 
variance) was used to examine, at one point in time, 
differences in ESDC total scores, MESSIER Positive total 
scores, and MESSIER Negative total scores between persons 
with and without Down’s Syndrome (independent variable #1 – 
“syndrome”) and persons assigned to the three perceived 
risk groups (independent variable #2 – “risk of dementia”).  
This analysis yielded significant main effects for 
“syndrome” (F(1,88)=4.566, p=.005)and for “risk of 
dementia” (F(2,87)=5.844, p=.000).  An interaction effect 
(syndrome * risk of dementia) was not identified 
(F(5,84)=1.020, p=.414).  Please refer to Table 4 for means 
and standard deviations. 
Tests of between subjects effects indicated that 
participants with Down’s Syndrome (M=14.22) had 
significantly lower scores on the MESSIER Negative scale 
(F(1,88)=13.491, p=.000) than participants without Down’s 
Syndrome (M=25.27).  Significant differences were not noted 
between the two syndrome groups on either the MESSIER 
Positive (F(1,88)=.084, p=.772) or ESDC Total scores 
(F(1,88)=1.491, p=.225). 
Significant differences on MESSIER Negative 
(F(2,87)=3.162, p=.047) and ESDC Total scores 
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(F(2,87)=18.759, p=.000) were noted among individuals 
assigned to the three “risk of dementia” groups.  A post 
hoc test indicated significant differences (p=.048) between 
the high and low risk groups on the MESSIER Negative scale 
(M=24.567 and M =15.333, respectively).   
Analysis revealed that the high risk group (M=8.467) 
was also significantly different from both the medium risk 
(M=4.033, p=.001) and low risk group (M=1.600, p=.000) on 
the ESDC Total score.  However, significant differences 
were not noted between the medium and low risk groups on 
any of the three assessment scales (MESSIER Positive 
p=.456, MESSIER Negative p=.557, ESDC p=.107). This 
indicates that, despite a mean age difference of 23.8 
years, scale scores were statistically similar among 
individuals who were not referred for neuropsychological 
assessment.   
     A separate analysis was completed on the total study 
sample (N=90) in order to investigate possible age effects.  
Participants were divided into 5 groups according to their 
chronological ages.  Group 1 was comprised of individuals 
between the ages of 30 and 39 years (N=28, Note: one 
subject was less than 30 years but they were included in 
group 1). Group 2 was made up of 12 individuals who were 
between 40 and 49 years.  There were 26 participants 
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between the ages of 50 and 59 years (group 3) and 19 
participants between the ages of 60 and 69 years (group 4).  
The fifth group contained all individuals who were 70 years 
and older (n=5).  A multivariate analysis of variance was 
conducted to determine whether there were significant 
differences across age groups in terms of ESDC, MESSIER 
Positive, and MESSIER Negative total scores.  Results 
showed that age had a significant effect on the ESDC scores 
(F(4,85)=4.651, p=.002).  Multiple comparisons were 
completed in order to determine among which age groups 
these differences were found.  Results showed that the 30-
39 year old group differed significantly from the 50-59 
year old group (p=.046) and from the 60-69 year old group 
(p=.031).  Age did not have a significant effect on either 
the MESSIER Positive (F(4,85)=.248, p=.910) or MESSIER 
Negative (F(4,85)=1.961, p=.108) scores. 
     Another series of multiple analyses of variance were 
run to investigate the effects of our participants’ 
demographic characteristics on the scale scores.  Two 
separate analyses were conducted to determine whether there 
were significant differences across gender groups and 
levels of mental retardation.  A significant difference 
between males and females was not found on any of the three 
dependent measures (ESDC – F(1,88)=.457, p=.501; MESSIER 
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Positive – F(1,88)=.004, p=.952; MESSIER Negative – 
F(1,88)=.466, p=.496).  However, a significant difference 
between levels of MR was obtained when examining MESSIER 
Positive scores (F(1,88)=13.16, p=.000).  Individuals with 
severe MR had significantly higher MESSIER Positive scores 
(M=102.48, SD=35.27) than participants diagnosed with 
profound MR (M=76.02, SD=31.59).  A significant difference 
between participants with severe and profound MR was not 
found on either MESSIER Negative (F(1,88)=.052, p=.821) or 
ESDC total scores (F(1,88)=.009, p=.923). 
Table 4 
Means and Standard Deviations for ESDC Total and MESSIER 











Mean S.D. Mean S.D. Mean S.D. 
D.S. 80.267 35.526 17.267 14.655 8.133 7.763High 
Non-D.S. 77.067 30.056 31.867 21.112 8.800 5.414
D.S. 87.267 37.107 14.000 8.036 2.533 2.642Medium 
Non-D.S. 100.800 29.898 24.667 13.500 5.533 3.159
Low D.S. 91.067 40.013 11.400 11.544 1.733 2.219
 Non-D.S. 74.333 35.407 19.267 13.419 1.467 2.200
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Cross Sectional Analysis of Clinical Symptoms 
The clinical signs of dementia (as measured by the 
ESDC) were investigated more closely with frequency counts 
and a multiple analysis of variance. Results showed that 
49% of our participants had at least one item endorsed on 
the “Decreased Performance” scale of the ESDC.   
Personality changes were endorsed for 44.4% of 
participants, indicating recent changes in mood and an 
exaggeration of personality traits.  Approximately one-
fourth (27.7%)of our participants presented with aspecific 
clinical symptoms such as a decrease in interest, speed and 
motivation.  Twenty seven percent of participants were 
noted to experience some deterioration in gait and 27.8% 
were beginning to occasionally show urinary incontinence.  
To a lesser degree, participants showed signs of spatial 
and temporal disorientation (13.3%) as well as 
deterioration in language skills (15.6%).  Only 6 of the 90 
participants demonstrated a loss of school-acquired skills, 
specifically deterioration in the ability to read and 
write, and only one participant developed epilepsy during 
the course of the study. 
A multivariate analysis of variance (MANOVA) was 
conducted in order to establish whether an individual’s 
“syndrome” or “risk of dementia” status influenced the 
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items endorsed on the ESDC.  The results indicated that a 
significant difference on the Personality Changes scale 
existed among participants with DS (M = .8889) and persons 
without DS (M = 1.4889) (F(1,88)= 6.231, p = .015).  
  Significant differences between “syndrome” groups were not 
noted on any other ESDC scales. 
A significant main effect for “risk of dementia” 
(F(2,87)=3.382, p=.000) was also noted.  Tests of between-
subjects effects indicated that significant values were 
obtained for all ESDC scales, with the exception of the 
Epilepsy scale (F(2,87)=1.000, p=.372).  Multiple 
comparisons were made (Sheffe post-hoc test) to identify 
the specific differences within the groups.  Significant 
differences were noted between the high and low risk groups 
on the following scales: General (p=.003), Personality 
Changes (p=.000), Decreased Performance (p=.000), 
Deterioration of Language Skills (p=.000), Deterioration of 
Gait (p=.002), Disorientation (p=.024), Incontinence 
(p=.025) and Loss of School Acquired Skills (p=.030).  
Significant differences between the high and medium risk 
groups were noted on the Decreased Performance (p=.001), 
Deterioration of Language Skills (p=.000) and Deterioration 
of Gait (p=.006) scales.  A significant difference was 
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noted between the medium and low risk group on the 
Personality Changes scale (p=.001). 
Longitudinal Analyses 
Because reliable diagnosis of dementia requires 
systematic documentation of age related performance 
declines within affected people (APA, 1994), a series of 
repeated measures analyses of variance were used to test 
for significant changes in social abilities over time.  The 
effects of referral status upon MESSIER Positive and 
MESSIER Negative scores were investigated with two separate 
two-way ANOVAs comparing the three “risk of dementia” 
groups over the three test administrations.  Main effects 
for “time” were noted for the MESSIER Positive 
(F(2,87)=4.217, p=.016) and MESSIER Negative scores 
(F(2,87)= 3.200, p= .043).However, a significant main 
effect for “risk of dementia” was not noted for either the 
MESSIER Positive (F(2,87)=1.093, p=.340) or MESSIER 
Negative scores (F(2,87)= .393, p= .676).  Significant 
interaction effects (Time * Risk of Dementia) were not 
noted for MESSIER Positive (F(5,84)=2.003, p=.096) or 
MESSIER Negative scores (F(5,84)= 2.001, p= .096). 
The effects of syndrome group upon MESSIER Positive 
and MESSIER Negative scores were also investigated.  Main 
effects for “time” were noted for the MESSIER Positive 
 72
(F(1,88)=4.078, p=.019) and MESSIER Negative scores 
(F(1,88)= 3.105, p= .047).  A significant main effect for 
“syndrome” was noted for MESSIER Negative scores (F(1,88)= 
237.147, p= .000) but not for MESSIER Positive scores 
(F(1,88)=1.093, p=.340). Significant interaction effects 
(Time * Syndrome) were not noted for MESSIER Positive 
(F(4,85)=2.003, p=.096) or MESSIER Negative scores 
(F(4,85)= .288, p= .750). 
Table 5 
Longitudinal Analysis of MESSIER Positive Scores 
 
 Administration 1 Administration 2 Administration 3 
DS M=92.86, SD=29.09 M=87.73, SD=27.18 M=80.27, SD=35.53 High 
Risk Non-DS M=91.13, SD=29.65 M=88.60, SD=35.31 M=77.07, SD=30.06 
DS M=89.20, SD=39.13 M=88.27, SD=35.28 M=87.27, SD=37.11 Medium 
Risk Non-DS M=104.60, SD=35.63 M=98.40, SD=32.90 M=100.80, SD=29.90 
DS M=94.33, SD=40.25 M=89.13, SD=36.39 M=91.07, SD=40.01 Low  




Longitudinal Analysis of MESSIER Negative Scores 
 
 Administration 1 Administration 2 Administration 3 
DS M=10.93, SD=10.74 M=15.27, SD=16.30 M=17.27, SD=14.66 High 
Risk Non-DS M=20.67, SD=14.07 M=22.80, SD=18.70 M=31.87, SD=21.11 
DS M=11.93, SD=5.84 M=11.67, SD=8.04 M=14.00, SD=8.04 Medium 
Risk Non-DS M=19.07, SD=11.28 M=24.00, SD=14.80 M=24.67, SD=13.50 
DS M=11.53, SD8.04 M=14.47, SD=9.65 M=11.40, SD=11.54 Low  











The life expectancy of adults with mental retardation 
has significantly increased in recent years (Silverman et 
al., 1998; Yang, Rasmussen & Friedman, 2000).  As a result, 
the prevalence of age-associated diseases such as dementia 
of the Alzheimer’s type has also risen (Zigman, Silverman, 
& Wisniewski, 1996).  Unfortunately, accurate prevalence 
rates are difficult to obtain because the evaluation and 
diagnosis of dementia in persons with MR is a complicated 
and involved process.  Due to these individuals’ life long 
histories of cognitive impairment and the potentially 
unique presentation of clinical symptoms of dementia in 
this population, valid assessment of dementia in persons 
with MR remains a problematic challenge.  In addition, 
although an increasing number of researchers are focusing 
on the aging process in persons with intellectual 
disabilities, comparison of experimental results is 
difficult due to the lack of uniform research methods and 
clear diagnostic criteria.  This study set out to replicate 
the diagnostic method proposed by Visser et al. (1997) on a 
sample of 90 developmentally disabled individuals with and 
without Down’s syndrome.  Prevalence rates and presenting 
symptoms were compared with Visser et al. (1997) results.  
Further analysis investigated the effects of age, sex, 
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level of MR, syndrome, and perceived risk of dementia on 
the participants’ assessment scores. 
We discovered that, during the course of three years, 
15 (16.7%) of our 90 participants developed symptoms of 
dementia compatible with Visser et al.’s (1997) criteria.  
Seven of those participants who met criteria had a co-
morbid diagnosis of Down’s syndrome.  These rates are very 
similar to results obtained by Visser et al. (1997) that 
showed that 18% of their patients with Down’s syndrome 
developed symptoms of dementia.  Also consistent with the 
results of Visser et al. (1997), our participants showed 
greatest decline in their ability to perform coordinated 
movements, as demonstrated by a poorer work performance, 
greater dependence on assistance to complete daily living 
skills, and onset of deterioration in their ability to 
perform household chores.  We acknowledge that, without 
postmortem examination, we cannot guarantee that our 15 
participants were truly showing symptoms indicative of 
dementia.  Visser et al. (1997) was able to provide more 
diagnostic confirmation by including EEG recordings in 
their screening.  Further confirmation was obtained for 
Visser at al. (1997) when a marked association was noted 
between their clinical diagnosis and neurological changes 
in the brains of 13 patients who died during the course of 
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their study.  However, because our methodology and 
diagnostic criteria were similar to Visser et al.’s (1997) 
study, we feel that we have successfully replicated their 
results and have demonstrated that the MESSIER is an 
appropriate substitute for the Social Skills Inventory for 
the Mentally Retarded. 
 Using a differential prevalence design we were able to 
compare our three risk groups (high = those referred by 
caretakers, medium = individuals 55 years and older who had 
not been referred, and low = individuals 40 years and 
younger who had not been referred).  Results indicated that 
the degree of deterioration of skills was significantly 
different among the groups, with the greatest proportion of 
persons demonstrating symptoms of dementia belonging to the 
high risk group.  However, it should be noted that though 
the Pearson chi-square statistic was significant (p=.012), 
it is possible that a difference was predicted that was not 
actually there.  Statisticians recommend that the chi 
square test not be used if any cell has an expected 
frequency of less than one or if more than 20% of the cells 
have an expected frequency of less than 5.  Though our 
expected frequencies were not less than one, six of our 12 
cells (50%) had an expected count less than 5. Thereby our 
cell frequencies were too low for chi square to be 
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appropriately used.  We could have placed greater 
confidence on our results if our sample size had been 
larger, thereby increasing the number of individuals in 
each cell.  However, because the number of individuals with 
Down’s syndrome that resided in the developmental center 
limited our total sample size to 90, it is suggested that 
data continue to be collected on the present sample.  The 
rationale for this is to determine whether our 
participants’ skills continue to deteriorate and whether 
the prevalence of individuals showing symptoms of dementia 
increases.  The length of our study was less than a third 
of Visser et al.’s (1997) 10-year study.  Three years may 
not be sufficient to observe significant declines. This 
will be discussed further in reference to the results of 
our longitudinal analysis. 
In addition to making a comparison with Visser et 
al.’s (1997) study, this study was designed to examine age-
related changes in behavioral and social functioning in 
individuals with and without Down’s syndrome over a three 
year period.  A number of recently published studies have 
established an association between Alzheimer’s dementia and 
Down’s syndrome (Crayton, Oliver, Holland, Bradbury & Hall, 
1998; Devenny, Krinsky-McHale, Serson, & Silverman, 2000; 
Holland, Hon, Huppert & Stevens, 2000).  Therefore, it was 
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hypothesized that persons with Down’s syndrome, 
particularly those who had been referred for a neurological 
assessment, would have higher scores on the ESDC total and 
MESSIER Negative scale, as well as lower MESSIER Positive 
scores than participants that did not have a co-morbid 
diagnosis of Down’s syndrome.  However, our results were 
inconsistent with studies that have found an accelerated 
rate of decline for persons with Down’s syndrome as 
compared to other individuals with mental retardation (Das, 
Mishra, Davison & Naglieri, 1995; Thompson, 2003). 
Significant differences between the syndrome groups were 
not noted in either ESDC total or MESSIER Positive scores.  
There are two possible explanations why differences between 
our “syndrome” groups were not observed.  Both explanations 
focus on our subjects’ level of mental retardation and how 
pre-morbid cognitive deficits can effect the scores of 
persons with and persons without Down’s syndrome.   
One explanation for the absence of significant 
differences between the “syndrome” groups is the effect of 
pre-morbid deficits upon the prevalence rates of our 
participants with Down’s syndrome.  In this present study, 
15.5% of our Down’s syndrome sample showed symptoms of 
dementia.  This is significantly lower than prevalence 
rates noted in the literature (Zigman, Schupf, Haveman & 
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Silverman, 1996).  For instance Holland et al. (2000) found 
that approximately 60% of their participants with Down’s 
syndrome developed dementia by the time they reached 60 
years of age. Unlike other studies that included persons 
functioning within the mild and moderate ranges of MR (Das, 
Mishra, Davison & Naglieri, 1995), this present study only 
contained persons with severe and profound MR.  It is 
believed that declines were not as evident for our sample 
because their low pre-morbid abilities made identification 
of further decline very difficult.  Deterioration in skills 
may have appeared small and slow because there was not 
enough room for further decline. 
The second, and more likely explanation considers the 
effect of pre-morbid functioning upon the non-Down’s 
syndrome group.  Although significantly fewer studies have 
looked at dementia in persons without Down’s syndrome, 
researchers have established much lower rates for this 
population in comparison to prevalence rates of persons 
with Down’s syndrome.  For instance, Janicki and Dalton 
(2000) found that 6.1% of their adults with MR but without 
Down’s syndrome were classified with dementia.  However, 
more than 17% of our participants demonstrated symptoms of 
dementia.  This accelerated rate may be explained by the 
“Reserve Capacity Model” (Mortimer, 1988).  The reserve 
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capacity model is based on research that shows that brain 
cells gradually die as people age (Jorm, 1996).  However, 
because most individuals have a sufficient “reserve 
capacity” of brain cells to compensate for these losses, 
declines in cognitive functioning are not immediately 
evident.  Signs and symptoms of dementia only appear when 
an excess of neurons are lost and compensation is no longer 
possible (Katzman, 1993).  The reserve capacity model 
states that persons who already have low levels of 
cognitive abilities (and for whom initial cognitive 
capacity is likely to be diminished) are at increased risk 
for dementia (Snowdon, Greiner, Kemper, Nanayakkara & 
Mortimer, 1999; Whalley et al., 2000).  Furthermore, 
individuals with lower levels of functioning (our subjects 
with severe and profound MR) are expected to experience an 
earlier onset of dementia symptoms and a faster rate of 
decline (Devenny et al., 1996; Temple, Joszvaki, 
Konstantareas & Hewitt, 2001).  It is hypothesized that 
individuals with severe and profound MR have accelerated 
rates of dementia because of limited brain cell reserve.  
The additional diagnosis of Down’s syndrome has little 
effect on persons already functioning at these low pre-
morbid states. 
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The only difference that was noted between our 
“syndrome” groups was on the MESSIER Negative scale.  We 
had predicted that, consistent with previous studies 
(Thompson, 1999), our Down’s syndrome group would show a 
greater amount of negative social behaviors than our non-
Down’s syndrome group.  However, the converse was actually 
found and our non-Down’s syndrome group demonstrated more 
negative behaviors.  We feel this may be related to 
behavioral phenotypes that have been associated with Down’s 
syndrome (Dykens & Kasari, 1997; Kasari & Freeman, 2001).  
Studies have shown that individuals with Down’s syndrome 
tend to be more social than individuals with MR due to 
other etiologies.  For instance, Kasari and Hodapp (1996) 
found that children with Down’s syndrome displayed greater 
amounts of social, engaging behavior than were typically 
found in other types of retardation.  These behavioral 
phenotypes may persist throughout the individual’s lifespan 
and make development of negative social behaviors less 
likely. 
These cross sectional analyses are, at best, an 
indirect reflection of the differences in these samples.  
Therefore caution needs to be used when interpreting these 
data because of methodological limitations associated with 
cross sectional studies (e.g., cohort effects and selective 
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survival).  In fact, it is believed that selective survival 
may have prevented us from observing the age effects that 
are common in dementia studies.  Selective survival is 
based on the notion that older age groups consist of a pool 
of surviving subjects and these survivors may have been 
individuals whose average health at age 40 was better than 
those who did not survive to old age (Strauss & Zigman, 
1996; Widaman et al, 1994).  This “selective survival” 
effect is likely to be a problem among adults with MR who 
are known to experience premature mortality (Burt et al., 
1995).  Our comparison of the medium (“old age”) and low 
risk group did not result in any significant differences in 
ESDC, MESSIER Positive or MESSIER Negative scores.  It is 
believed that, due to selective survival, our sample of 
older adults (medium risk group) may have been more fit 
than our sample of younger adults (low risk group).  Thus, 
our older group may have been unrepresentatively healthy 
whereas it is likely that our younger group was made up of 
future survivors and non-survivors.  Further evidence of 
selective survival is demonstrated by the scores of our 
Down’s syndrome participant who was over the age of 70.  
This individual had no items endorsed on the ESDC, his 
MESSIER Positive score was higher than the mean of any 
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other age group, and his MESSIER Negative score was lower 
than the mean of any other age group. 
Researchers have long established that the preferred 
design for a study of aging is a longitudinal design.  In 
such a design, cohort effects would not be confounded with 
age effects (Salthouse, 1982).  A repeated measure ANOVA 
was used to test for significant changes in MESSIER 
Positive and MESSIER Negative scores over time with the 
expectation that longitudinal changes would not be evident 
in the low risk group, would be evident in the medium risk 
group, and would be most evident in the high risk group.  
Changes in scores were noted over the three test 
administrations but the rate of decline was statistically 
similar across all groups regardless of their “risk of 
dementia” or “syndrome” status.   
The length of our longitudinal study may provide a 
possible explanation why significant main effects for 
“syndrome” and “risk of dementia” or significant 
interaction effects for “time * syndrome” and “time * risk 
of dementia” were not found.  Previous studies that have 
shown differential rates were conducted for a longer 
duration (e.g., Visser et al. (1997) monitored their 
participants for up to 10 years).  Or, the period between 
pre- and post-tests was longer (e.g., Holland and Hon 
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(1996) waited 18 months before re-administering their 
assessments).  Once again, it is suggested that data 
continue to be collected on this sample to determine 
whether the rates of decline continue to change as time 
passes. 
This present study had several limitations.  As 
mentioned, the duration of the study may not have been long 
enough and one year between test administrations may not 
have been sufficient enough to see a decline in skills.  A 
second limitation was our sample size.  We had difficulty 
finding potential participants with Down’s syndrome who fit 
our criteria (persons with severe or profound MR, 
individuals between the ages of 25-40 or 55 years and 
older) so this ultimately resulted in small cell sizes in 
our bivariate table.  Also, because this study only 
involved an institutionalized population, our results 
cannot be directly projected to non-institutionalized 
individuals with mental retardation.  The greatest 
limitation is that we have no pathology findings for any of 
our cases that show symptoms of dementia.  Therefore, 
although we can hypothesize that the observed declines in 
social and behavioral functioning are due to dementia, we 
cannot confirm this without autopsy findings. 
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Overall, results of this study indicate that the 
Visser et al. (1997) method was useful in distinguishing 
between “risk of dementia” groups.  Although differences 
between syndrome groups were not as large as anticipated, 
valuable information was obtained regarding the signs, 
symptoms and course of dementia in persons with 
intellectual disabilities.  In addition, this study 
provides further support that, though caregiver reports are 
useful in identifying functional impairments, clinicians 
should not wait for a referral before completing a dementia 
assessment on an aging individual.  Though the high risk 
group (those referred by caregivers) contained the largest 
proportion of persons meeting Visser et al. (1997) criteria 
for dementia, testing demonstrated that 10% of non-referred 
individuals also showed signs of deterioration.  Therefore, 
all individuals with developmental delays should undergo a 
comprehensive evaluation by the age of 25 years and testing 
should be repeated at least once every five years to assess 
for declines in functioning (Aylward et al., 1995).   
This is particularly important because assessment may 
allow clinicians to detect dementia early enough stage to 
to attempt to slow the individual’s cognitive decline with 
medication.  Although there is no cure for dementia of the 
Alzheimer’s type, there are a number of drugs available 
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that have shown effective in stabilizing the symptoms of 
dementia, thus improving well being and easing caregiver 
burden.  The drugs that have been most widely used include 
the cholinesterase inhibitors: donepezil (Aricept), 
galantamine (Reminyl), and rivastigmine (Exelon) and a 
glutamate blocker: memantine (Namenda). (Reisberg et al., 
2003; Winblad & Portis, 1999).  
Identification of the onset of deterioration should 
also influence treatment planning. Training priorities 
should change once progressive delays are identified.  For 
instance, the focus of treatment can be teaching these 
individuals alternate modes of communicating their wants 
and needs and preserving whatever intact communication 
skills there are.  Social skills training may also be 
beneficial but with a focus of training shifted from new 
skills acquisition to current skills preservation.  This 
may enhance the quality of their lives by sustaining their 
ability to participate in interpersonal interactions and 
thus thwart or even just postpone the course and pace of 
deterioration (Walsh et al., 2001).  In addition, educating 
staff members of the dementing process and providing 
guidelines for caring for persons clinically diagnosed with 
dementia may improve the quality of the clients’ lives and 
enhance the staffs’ caregiver roles by allowing their 
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attitude to change their caregiving activities as clients’ 
needs and abilities change (Engelman, Altus & Matthews, 
1999). Thus, changing training priorities can have a 
dramatic impact on the resident’s activities of daily 
living and perhaps postpone their transfers to a more 
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